These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alfa-antitrypsin increase in lung cancer. Daddi G; Mancini PA; Parola D; Contini A Boll Ist Sieroter Milan; 1976; 55(6):510-2. PubMed ID: 1088073 [TBL] [Abstract][Full Text] [Related]
5. [Proteolytic enzymes and their inhibitors in clinical and experimental oncology]. Geshelin SA; Vovchuk SV; Blizniuk BF; Varbanets VF Vopr Onkol; 1984; 30(10):9-18. PubMed ID: 6208687 [No Abstract] [Full Text] [Related]
6. [Characteristics of the lactate dehydrogenase isoenzyme spectrum of malignant and benign human tumors]. Gorozhanskaia EG; Shapot VS Vestn Akad Med Nauk SSSR; 1971; 26(3):28-32. PubMed ID: 5581444 [No Abstract] [Full Text] [Related]
7. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer]. Kovcić V; Jelić S; Filipović I; Tomasević Z Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404 [TBL] [Abstract][Full Text] [Related]
8. Alpha-1 antitrypsin phenotypes in patients with lung, prostate and breast cancer. El-Akawi ZJ; Al-Hindawi FK Saudi Med J; 2004 Feb; 25(2):186-9. PubMed ID: 14968215 [TBL] [Abstract][Full Text] [Related]
9. [Serum alpha 1-antitrypsin in lung cancer]. Biesiekierska-Chańko I Pol Tyg Lek; 1981 Jul; 36(30):1139-41. PubMed ID: 6975927 [No Abstract] [Full Text] [Related]
10. [Several peculiarities of hexokinase of malignant and benign tumors in man]. Liubimova NV; Gorozhanskaia EG Eksp Onkol; 1984; 6(5):42-6. PubMed ID: 6542490 [TBL] [Abstract][Full Text] [Related]
12. Acid phosphatase of neutrophils in patients with malignancies. Lisiewicz J; Moszczyński P Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):595-8. PubMed ID: 6083932 [TBL] [Abstract][Full Text] [Related]
13. Altered carbohydrate content of alpha1-antitrypsin in patients with cancer. Rostenberg I; Guízar-Vázquez J; Peñaloza R J Natl Cancer Inst; 1978 Oct; 61(4):961-5. PubMed ID: 309009 [TBL] [Abstract][Full Text] [Related]
14. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of alpha-1-antitrypsin in pancreatic islet cell tumors. Prinz RA; Sandberg L J Med; 1984; 15(3):177-83. PubMed ID: 6098624 [TBL] [Abstract][Full Text] [Related]
16. [Hexokinase isoenzyme in human malignant tumor tissues]. Neĭfakh SA; Monakhov NK; Shvartsman AL Dokl Akad Nauk SSSR; 1972 Sep; 206(3):743-6. PubMed ID: 4655468 [No Abstract] [Full Text] [Related]
17. Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients. El-Akawi ZJ; Nusier MK; Zoughool FE Saudi Med J; 2006 Feb; 27(2):181-4. PubMed ID: 16501672 [TBL] [Abstract][Full Text] [Related]
18. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease. Gadek JE; Fulmer JD; Gelfand JA; Frank MM; Petty TL; Crystal RG J Clin Invest; 1980 Jul; 66(1):82-87. PubMed ID: 6967489 [TBL] [Abstract][Full Text] [Related]
19. [Determination of superoxide dismutase (SOD) in serum of cancer patients by microchemical luminescence]. Dai R Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):272-4. PubMed ID: 2625108 [TBL] [Abstract][Full Text] [Related]
20. Occurrence of L-lysine dehydrogenase (LyDH) in human serum in normal and some pathological states. Bürgi W; Schärer HU Helv Med Acta; 1967 Dec; 34(1):84-90. PubMed ID: 5631604 [No Abstract] [Full Text] [Related] [Next] [New Search]